These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 10360262)

  • 1. Telomerase activity in complete hydatidiform mole.
    Sukcharoen N; Mutirangura A; Limpongsanurak S
    J Reprod Med; 1999 May; 44(5):465-70. PubMed ID: 10360262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preevacuation serum CA 125 in complete hydatidiform mole.
    Tangtrakul S; Srisupandit S; Chailurkit LO; Rajatanavin R
    Gynecol Oncol; 1997 Mar; 64(3):487-9. PubMed ID: 9062156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in complete hydatidiform mole.
    Bae SN; Kim SJ
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):328-33. PubMed ID: 9988795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete hydatidiform mole and a coexistent viable fetus: report of two cases and review of the literature.
    Bruchim I; Kidron D; Amiel A; Altaras M; Fejgin MD
    Gynecol Oncol; 2000 Apr; 77(1):197-202. PubMed ID: 10739712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of twin pregnancy with complete hydatidiform mole and coexisting fetus.
    Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
    Obstet Gynecol; 1994 Jan; 83(1):35-42. PubMed ID: 8272304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
    Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
    BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive complete and partial hydatidiform mole.
    Rice LW; Lage JM; Berkowitz RS; Goldstein DP; Bernstein MR
    Obstet Gynecol; 1989 Aug; 74(2):217-9. PubMed ID: 2748058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human telomerase reverse transcriptase, the catalytic subunit of telomerase, is associated with the development of persistent disease in complete hydatidiform moles.
    Amezcua CA; Bahador A; Naidu YM; Felix JC
    Am J Obstet Gynecol; 2001 Jun; 184(7):1441-6. PubMed ID: 11408866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinicopathologic study of 153 cases of complete hydatidiform mole (1980-1990): histologic grade lacks prognostic significance.
    Genest DR; Laborde O; Berkowitz RS; Goldstein DP; Bernstein MR; Lage J
    Obstet Gynecol; 1991 Sep; 78(3 Pt 1):402-9. PubMed ID: 1876374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of persistent disease in women with complete hydatidiform mole.
    Ayhan A; Tuncer ZS; Halilzade H; Küçükali T
    J Reprod Med; 1996 Aug; 41(8):591-4. PubMed ID: 8866387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
    Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in current clinical features of diploid and triploid hydatidiform mole.
    Niemann I; Petersen LK; Hansen ES; Sunde L
    BJOG; 2007 Oct; 114(10):1273-7. PubMed ID: 17655732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.